World Health Organization

Consultants Pharmacovigilance Systems Strengthening

World Health Organization View all jobs


Botswana
Permanent
Pharmaceutical

Posted 14 day(s) ago

Reference: 2432729


Consultants Pharmacovigilance Systems Strengthening - (2603995)

Contractual Arrangement: External consultant

Contract Duration (Years, Months, Days): 3 Months

Job Posting

: Oct 12, 2026, 7:05:34 AM

Closing Date

: Oct 26, 2026, 6:59:00 PM

Primary Location

: Botswana-Gaborone

Organization

: AF_BWA Botswana

Schedule

: Full-time

IMPORTANT NOTICE: Please note that the deadline for receipt of applications indicated above reflects your personal device's system settings.

..

Output 1.1: Conduct a detailed landscape and SWOT analysis of vigilance systems within the BoMRA and related stakeholders in Botswana.

Output 1.2: Review guidelines, Standard Operating Procedures (SOPs) working tools, and regulatory actions and decisions aligned with WHO Global benchmarking standards.

Output 1.3: Provide review of

- Evaluation of Risk Management Planning (RMP) and related documents

- Safety Communication and Vigilance data Publication

- Vigilance documents during conduct of Good Vigilance Inspections

- Implementation of IDPs at Adverse Drug Reaction Monitoring Centres (AMCs) against the Field Visit Manual for Assessing the Performance of Vigilance Function

Output 1.4: Provide guidance on communication to BoMRA stakeholders on

- Activities to be conducted to enhance understanding and compliance to regulations and guidelines

1. Deliverables:

· Monthly Progress Reports - Monthly written reports summarizing:

· Activities conducted Progress against IDP milestones

· Challenges encountered and mitigation actions

· Recommendations for the next period

· Comprehensive end of activity report on vigilance systems within the BoMRA and stakeholders, including activities conducted and recommendations on how to strengthen existing systems.

· GBT implementation status >95% completion by March 2027.

· Review of training materials, including presentations, handouts, and session summaries for safety surveillance and causality assessment.

· Recommendations for sustaining and accelerating progress